Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
6,556,396
-
Share change
-
+351,122
-
Total reported value
-
$509,704,617
-
Put/Call ratio
-
13%
-
Price per share
-
$77.74
-
Number of holders
-
111
-
Value change
-
+$29,919,137
-
Number of buys
-
52
-
Number of sells
-
34
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2022
As of 31 Dec 2022,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,556,396 shares.
The largest 10 holders included
Phoenix Holdings Ltd., GOLDMAN SACHS GROUP INC, UBS Group AG, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, BANK OF AMERICA CORP /DE/, Prime Capital Investment Advisors, LLC, MORGAN STANLEY, LPL Financial LLC, BNP PARIBAS ARBITRAGE, SNC, and VALICENTI ADVISORY SERVICES INC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.